Cargando…

The Contrived Mutant p53 Oncogene – Beyond Loss of Functions

Mutations in p53 are almost synonymous with cancer – be it susceptibility to the disease or response to treatment – and therefore, are a critical determinant of overall survival. As most of these mutations occur in the DNA-binding domain of p53, many of the clinical correlations with mutant p53 have...

Descripción completa

Detalles Bibliográficos
Autor principal: Sabapathy, Kanaga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674554/
https://www.ncbi.nlm.nih.gov/pubmed/26697411
http://dx.doi.org/10.3389/fonc.2015.00276
_version_ 1782404911644803072
author Sabapathy, Kanaga
author_facet Sabapathy, Kanaga
author_sort Sabapathy, Kanaga
collection PubMed
description Mutations in p53 are almost synonymous with cancer – be it susceptibility to the disease or response to treatment – and therefore, are a critical determinant of overall survival. As most of these mutations occur in the DNA-binding domain of p53, many of the clinical correlations with mutant p53 have been initially relegated to the loss of its transcription-dependent activities as a tumor suppressor. However, significant efforts over the last two decades have led to the vast knowledge on the potential functions of the mutated p53 protein, which have been attributed to the physical presence of the mutant protein rather than the loss of its wild-type (WT) functions. Beyond the inhibitory effects of mutant p53 on the remaining WT protein that leads to the dominant-negative effect in the heterozygous state, mutant p53’s presence has also been significantly attributed to novel gain-of-functions that lead to addiction of cancer cells to its presence for survival, as well as for their ability to invade and metastasize, elevating it to a contrived oncogene that drives the cancer cells forward. This review will summarize the functional consequences of the presence of mutant p53 protein on cellular and organismal physiology.
format Online
Article
Text
id pubmed-4674554
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-46745542015-12-22 The Contrived Mutant p53 Oncogene – Beyond Loss of Functions Sabapathy, Kanaga Front Oncol Oncology Mutations in p53 are almost synonymous with cancer – be it susceptibility to the disease or response to treatment – and therefore, are a critical determinant of overall survival. As most of these mutations occur in the DNA-binding domain of p53, many of the clinical correlations with mutant p53 have been initially relegated to the loss of its transcription-dependent activities as a tumor suppressor. However, significant efforts over the last two decades have led to the vast knowledge on the potential functions of the mutated p53 protein, which have been attributed to the physical presence of the mutant protein rather than the loss of its wild-type (WT) functions. Beyond the inhibitory effects of mutant p53 on the remaining WT protein that leads to the dominant-negative effect in the heterozygous state, mutant p53’s presence has also been significantly attributed to novel gain-of-functions that lead to addiction of cancer cells to its presence for survival, as well as for their ability to invade and metastasize, elevating it to a contrived oncogene that drives the cancer cells forward. This review will summarize the functional consequences of the presence of mutant p53 protein on cellular and organismal physiology. Frontiers Media S.A. 2015-12-10 /pmc/articles/PMC4674554/ /pubmed/26697411 http://dx.doi.org/10.3389/fonc.2015.00276 Text en Copyright © 2015 Sabapathy. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Sabapathy, Kanaga
The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
title The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
title_full The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
title_fullStr The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
title_full_unstemmed The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
title_short The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
title_sort contrived mutant p53 oncogene – beyond loss of functions
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674554/
https://www.ncbi.nlm.nih.gov/pubmed/26697411
http://dx.doi.org/10.3389/fonc.2015.00276
work_keys_str_mv AT sabapathykanaga thecontrivedmutantp53oncogenebeyondlossoffunctions
AT sabapathykanaga contrivedmutantp53oncogenebeyondlossoffunctions